SCHEMBL12369293

SCHEMBL12369293

CCOC(=O)[C@@]12C[C@H]1/C=C\CCC/C=N/C(=O)[C@@H]1C[C@@H](CC(C)(C)[Si](C)(C)O)CN1C(=O)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13531195 0.86 CTSB (0.32) —
SCHEMBL12368021 0.84 — —
SCHEMBL12368022 0.84 — —
SCHEMBL13531207 0.79 GABRA1 (0.31) —
SCHEMBL13531204 0.76 ADRB3 (0.30) —
SCHEMBL13951697 0.73 — —
SCHEMBL13530914 0.70 CTSB (0.31) —
SCHEMBL15216165 0.69 CTSB (0.32) —
SCHEMBL10283470 0.69 CTSB (0.32) —
SCHEMBL10283465 0.69 CTSB (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003659-B2 Macrocyclic serine protease inhibitors INDENIX PHARMACEUTICALS, INC. (US) 2011-08-23 — — US disclosed
Send feedback